Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Synthetic Biology Taps DNA's Business Potential

Abstract:
"Synbio" sparking changes in energy, healthcare and agriculture according to Lux Research

Synthetic Biology Taps DNA's Business Potential

Boston, MA | Posted on February 26th, 2009

Promising everything from algae-derived petroleum to personalized medicine to drought-resistant crops, synthetic biology - or synbio - is rapidly sprouting disruptive new technologies in energy, healthcare, specialty chemicals, and agriculture. Despite the diverse and explosive nature of synbio's growth opportunities, however, there's been little or no meaningful commercial analysis of the field to date.

Until now… Following close review of dozens of companies, thousands of practitioners and over $1 billion in investments, Lux Research this week introduced the synbio sector's first-ever strategic market report. Entitled "Synthetic Biology's Commercial Roadmap," the report provides a definitive summation of potential opportunities enabled through the "discovery, invention, and manufacture of biochemical elements and systems to produce tools, materials, organisms, and devices that meet human needs."

Corporate decision-makers responsible for R&D, partnerships and business development will all find in Lux's roadmap a framework to help them separate hype from reality and identify synbio's real-world economic opportunities. The report offers intelligence on:

· The types of products enabled by synthetic biology, and where and when those products will become commercially competitive in select industries;

· Where the venture opportunities are today, where they will emerge tomorrow;

· What economic and scientific hurdles synbio technologies still need to negotiate.

"As a rule of thumb, we found that the higher up an application is on the scale of life, the more distant its commercialization launch," said Mark Bünger, a Research Director at Lux Research and the report's lead author. "Start-ups sequencing or synthesizing DNA to program microbes, for example, are already operating in established markets and with well-defined products like biofuels, drugs, and specialty chemicals. Meanwhile, engineered cells leading to devices like DNA circuits or biosensors remain at the proof of concept stage."

To map the outlines of the synbio sector, the authors visited leading labs, spoke with scientists and investors, and evaluated 72 companies' activities through a combination of executive interviews and secondary research. They examined 231 patents and 615 scientific papers that comprise the formal body of intellectual property, and spotted 41 private investments in the space to date. Among their key findings:

· Incumbent corporations are investing directly into startups - such as Chevron's funding of Solazyme - while top VCs like Khosla Ventures and Kleiner Perkins are putting hundreds of millions of dollars into fuel- and medicine-makers like Amyris, LS9 and Gevo.

· Noncorporate organizations like the iGEM competition are using the open-source software movement as a model, and playing a central role in advancing synthetic biology.

· Government funding is more coordinated in Europe, led by the EU's 6th Framework program (FP6) which provides millions of euros in funding for 18 synthetic biology research and policy initiatives and five economic development projects.

"Countless commercially valuable materials like penicillin and crude oil, and processes like carbon sequestration and bioremediation, all derive from plants' and animals' metabolic pathways, which are in turn determined by their genes," said Bünger. "Synthetic biology has opened new pathways for us to reprogram those metabolic pathways like software, and design products in countless industries with a revolutionary new degree of freedom."

"Synthetic Biology's Commercial Roadmap" is part of Lux Research's Bioscience Intelligence Service. Clients subscribing to this service receive continuous research on the biosciences industry, market trends and forecasts, ongoing technology scouting reports and proprietary data points in the weekly Lux Research Bioscience Journal and on-demand inquiry with Lux Research analysts.

####

About Lux Research, Inc.
Lux Research provides strategic advice and on-going intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients.

For more information, please click here

Contacts:
Carole Jacques
Lux Research, Inc.
617-502-5314

Copyright © Lux Research, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

New research points to graphene as a flexible, low-cost touchscreen solution September 19th, 2014

Synthetic Biology

Artificial Cells Act Like the Real Thing: Cell-like compartments produce proteins and communicate with one another, similar to natural biological systems August 18th, 2014

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014

Artificial cilia: Scientists from Kiel University develop nano-structured transportation system July 4th, 2014

Artificial enzyme mimics the natural detoxification mechanism in liver cells: Molybdenum oxide particles can assume the function of the endogenous enzyme sulfite oxidase / Basis for new therapeutic application June 30th, 2014

Announcements

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

New research points to graphene as a flexible, low-cost touchscreen solution September 19th, 2014

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

New research points to graphene as a flexible, low-cost touchscreen solution September 19th, 2014

CiQUS researchers design an artificial nose to detect DNA differentiation with single nucleotide resolution September 18th, 2014

Recruiting bacteria to be technology innovation partners: September 17th, 2014

Food/Agriculture/Supplements

Nanoscience makes your wine better September 17th, 2014

Newly-Developed Nanosensor Controls Amount of Edible Dyes in Foodstuff Products September 5th, 2014

Iran Unveils 5 Home-Made Knowledge-Based Products August 25th, 2014

Nanotechnology Helps Production of Super Adsorbent Polymers August 21st, 2014

Energy

IEEE International Electron Devices Meeting To Celebrate 60th Anniversary as The Leading Technical Conference for Advanced Semiconductor Devices September 18th, 2014

Rice rolls 'neat' nanotube fibers: Rice University researchers' acid-free approach leads to strong conductive carbon threads September 15th, 2014

Simple, Cost-Effective Method Proposed for Synthesizing Zinc Oxide Nanopigments September 15th, 2014

UT Arlington research uses nanotechnology to help cool electrons with no external sources September 11th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE